Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
A recent paper suggests younger children with acne vulgaris should be treated the same as adolescents. This includes utilizing combination therapies that may consist of topic retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics.
Younger children with acne should be treated the same as adolescents, using combination therapy that may include topical retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics, according to a recent paper.1
Written by an expert panel of nine pediatric dermatologists, the article is thought to be the first-ever published report to focus on acne in young pediatric patients and provides a guide to the evaluation and management of acne in children ages birth to 12 years,1 according to panel member Bernard A. Cohen, MD, professor of dermatology and pediatrics, Johns Hopkins University School of Medicine, Baltimore.
“Acne affects children of all ages," says Cohen. "With a decline in the age accepted as normal for onset of puberty, we are now seeing acne more often in children who would be categorized as preadolescents based on chronological age. In addition, a number of new medications approved for use in children ages 9 years and older have become available.”
The consensus addresses patient assessment and treatment in an age-related context, including approved and off-label use of the expanded treatment armamentarium. “As a panel participant, it was remarkable to me that our group reached unanimous consensus on all seven statements included in the paper,” he adds.
Their recently published article presents seven panel-defined consensus statements based on information from 32 articles identified through a systematic literature review together with insights from expert opinion and experience.
Disclosures: Research for the consensus report was supported by an unrestricted educational grant from Almirall. Dr. Cohen has no relevant financial interests to disclose.
Reference: 1 Schachner LA, Eichenfield L, Andriessen A, et al. Consensus on neonatal through preadolescent acne. J Drugs Dermatol. 2020;19(6):592-600.